Loading clinical trials...
Loading clinical trials...
Voglibose Tablets 0.2 / Voglibose Oral Disintegrant (OD) Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"
Conditions
Interventions
Voglibose
Locations
1
Japan
Osaka, Japan
Start Date
November 18, 2009
Primary Completion Date
August 31, 2013
Completion Date
August 31, 2013
Last Updated
December 4, 2018
NCT07286747
NCT07440147
NCT06964620
NCT06697756
NCT06895161
NCT06537401
Lead Sponsor
Takeda
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions